bioRxivNeurosciencePreprint
CellPHIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology
Byunguk KangiD, Michael A. MurphyiD, Christopher NgiD, Matthew Joseph LeventhaliD, Nhan C. HuynhiD, Egun Im, Serwah A. DanquahiD, David E. HousmaniD, Ralda NehmeiD, Samouil L. FarhiiD, Ernest FraenkeliD
Abstract
Genomic screens and GWAS are powerful tools for identifying disease-modifying genes, but it is often challenging to understand the pathways by which these genes function. Here, we take an integrated approach that combines network analysis and an imaging-based pooled genetic perturbation study to examine modifiers of Huntingtons disease (HD). The computational analysis highlighted several genes in a subnetwork enriched for modifiers of neuronal development and morphology. To test the functional roles of these genes, we developed an experimental pipeline that allows pooled CRISPRi KD of 21 genes in human iPSC-derived neurons followed by optical analysis of genotypes, neuronal arborization, multiplexed pathway activity and morphological fingerprint readout. This approach recovered known genes involved in morphology and confirmed unexpected links from the network between several genetic modifiers of HD and morphology. Our approach overcomes challenges in pooled measurement of neuronal function and health and could be adapted for other phenotypes in HD and other neurological diseases.
- organism: human
- assay: CRISPR screen
- research focus: perturbation response prediction
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-scale Perturbation of Systems Biology-Derived Genes Reveals Modifiers of HD-associated Transcriptomic Networks and Pathology
Peter Langfelder, Nan Wang, … X. William Yang·bioRxiv·Mar 4, 2026
- Protective role of Pten downregulation in Huntington's Disease models
Nisha Nisha, Deepti Thapliyal, … Mayanglambam Dhruba Singh·bioRxiv·Mar 28, 2024
- CryoET Reveals Organelle Phenotypes in Huntington Disease Patient iPSC-Derived and Mouse Primary Neurons
Gong‐Her Wu, Charlene Smith-Geater, … Wah Chiu·Nature CommunicationsPeer-reviewed·Feb 8, 2023
- Transcriptomic Characterization Reveals Disrupted Medium Spiny Neuron Trajectories in Huntington's Disease and Possible Therapeutic Avenues
Carlos Galicia Aguirre, Kizito‐Tshitoko Tshilenge, … Lisa Ellerby·bioRxiv·Apr 30, 2023
- Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
Galen E.B. Wright, Nicholas S. Caron, … Michael R. Hayden·Human Molecular GeneticsPeer-reviewed·Aug 12, 2020
- In vivo progressive degeneration of Huntington's disease patient-derived neurons reveals human-specific pathological phenotypes
Andrés Miguez, Sara Fernández‐García, … Josep Maria Canals·bioRxiv·Oct 21, 2020